Form 8-K - Current report:
SEC Accession No. 0001193805-24-001318
Filing Date
2024-11-07
Accepted
2024-11-07 16:25:35
Documents
14
Period of Report
2024-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e663993_8k-arct.htm   iXBRL 8-K 28727
2 e663993_99-1.htm EX-99.1 70872
  Complete submission text file 0001193805-24-001318.txt   286669

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE arct-20241107.xsd EX-101.SCH 3021
4 XBRL LABEL FILE arct-20241107_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE arct-20241107_pre.xml EX-101.PRE 22363
16 EXTRACTED XBRL INSTANCE DOCUMENT e663993_8k-arct_htm.xml XML 3712
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 241436238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)